The MGH Brain Photobiomodulation Lab, operating under Dr. Paolo Cassano, conducts research with a variety of clinical populations. Each study evaluates the efficacy of transcranial photobiomodulation, or near-infrared light therapy, on improving clinical symptoms associated with various conditions, including depression, bipolar and anxiety. One current study is for individuals with Major Depressive Disorder. They collect data and monitor progress through peer-reviewed clinical scales, neuropsychological testing, and neuroimaging techniques.
Bio of Paolo Cassano, MD, PhD
Dr. Cassano is an Associate Professor in Psychiatry at Harvard University, and Director of Photobiomodulation at the MGH Division of Neuropsychiatry and at the MGH Depression Clinical and Research Program.
Dr. Cassano has served as a principal investigator on multiple studies on transcranial photobiomodulation for various neuropsychiatric disorders, including major depressive disorder and bipolar disorder. and generalized anxiety disorder.
Zoom Room Link: https://zoom.us/j/86050953710
Note: This Zoom room does not require a password.
Date: Tuesday, March 25, 2025
Time: 7:00–8:15 p.m. ET
Speakers’ Series Co-Chairs:
Cynthia Piltch: Cynthia@dbsaboston.org
Alisa Stepanian: Alisa@dbsaboston.org